The mechanistic and clinical significance of complex fractionated atrial electrograms (CFAE) in the coronary sinus (CS) has been unclear.
Introduction
Complex fractionated atrial electrograms (CFAEs) may indicate atrial sites that play a role in the genesis of atrial fibrillation (AF). 1, 2 CFAEs are prevalent in the antral regions of the pulmonary veins (PVs). CFAEs are often targeted at other left atrial sites, particularly in patients with chronic AF.
(CS). However, the mechanistic and clinical significance of CFAEs in the CS has not been well defined. For example, it is unclear whether CFAEs in the CS reflect primary drivers of AF or develop as a result of wavebreak/fibrillatory conduction, 5 or from summation of electrograms from overlapping muscle fibers of the coronary sinus and left atrium. 6 The purpose of this study was to better understand the mechanistic and clinical significance of CFAEs within the CS by examining: (1) their time-and frequency-domain characteristics; (2) the effects of antral pulmonary vein isolation (APVI) on CS CFAEs; and (3) the relationship between CFAEs before and after APVI and clinical outcome in patients with paroxysmal and persistent AF.
Methods

Study Subjects
The subjects of this study were 77 consecutive patients who underwent APVI for paroxysmal (32) or persistent (45) AF. The mean age of the patients was 60 ± 10 years. There were 57 men and 20 women. AF was first diagnosed 5 ± 5 years before referral. The mean left ventricular ejection fraction was 0.56 ± 0.11. The mean left atrial diameter was 39 ± 5 mm in patients with paroxysmal AF and 47 ± 5 mm in patients with persistent AF (P < 0.001). Structural heart disease was present in 43 patients (56%): hypertensive heart disease in 26 patients, coronary artery disease in 10, and a nonischemic cardiomyopathy in seven patients. Patients who had undergone a prior ablation procedure for AF were excluded from this study.
Electrophysiologic Study
All patients provided informed written consent. Electrophysiological studies were performed in the fasting state. All antiarrhythmic medications, except for amiodarone in seven patients (9%), were discontinued five half-lives before the procedure. Amiodarone was discontinued 6-8 weeks prior to the procedure. Vascular access was obtained through a femoral vein. A steerable quadripolar catheter with 2.5 mm interelectrode spacing (EP Technologies, Sunnyvale, CA, USA) was positioned in the CS and was used for recording and atrial pacing. The position of the CS catheter was confirmed periodically by fluoroscopy throughout the procedure. After transseptal puncture, systemic anticoagulation was achieved with intravenous heparin to maintain an activated clotting time of 300 to 350 seconds. The pulmonary veins (PVs) were mapped with a decapolar ring catheter (Lasso, Biosense Webster, Diamond Bar, CA, USA). An open-irrigation, 3.5-mm-tip deflectable catheter (Thermocool, Biosense Webster) was used for mapping and ablation. Bipolar electrograms were displayed at filter settings of 30 to 500 Hz during the procedure (EPMed Systems). Electrograms from the CS also were recorded at a band-pass of 0.5-200 Hz for off-line spectral analysis.
Radiofrequency Catheter Ablation
Left atrial and PV geometry was reconstructed in 3-D using an electroanatomical mapping system (Carto, BiosenseWebster) and was merged with a preacquired CT image (CartoMerge, Biosense-Webster). CFAEs within the antral regions of the right-and left-sided PVs were ablated. The endpoint of ablation was complete isolation of all PVs and elimination of all antral CFAEs. Sinus rhythm was restored by cardioversion in patients who remained in AF after APVI.
Radiofrequency energy applications had a maximum power of 35 W at a flow rate of 30 mL/min and a maximum temperature of 50
• C. Near the ostium of the PVs and at posterior left atrium, the radiofrequency energy was delivered at a maximum power of 25 W with a maximum temperature of 50
• C.
Study Protocol
The study protocol was approved by the Institutional Review Board. Eight of the 32 patients with paroxysmal AF and all of the 45 patients with persistent AF were in AF upon presentation to the laboratory. AF was induced by isoproterenol and/or rapid atrial pacing in the remaining 24 patients with paroxysmal AF.
Electrograms in the CS were recorded for 60 seconds during AF before and after APVI. Among patients in whom AF was induced, electrograms were recorded ≥10 minutes after induction of AF. Baseline electrograms were recorded immediately before the first application of radiofrequency energy.
In patients who remained in AF after ablation, electrograms were recorded during AF upon completion of APVI. Twentyfour patients in whom AF terminated during ablation, electrograms recorded 2 minutes before termination of AF were used for analysis.
Digital Signal Processing
Electrograms recorded in the CS were processed and analyzed off-line in the MatLab environment (MathWorks, Natick, MA, USA ) using custom software. First, QRS complexes were subtracted as described previously. 7 The threshold for detection was defined as ± 0.05 of the mean of the maximum 60 electrogram amplitudes in a sampling window. All data and electrograms were reviewed manually and appropriateness of detection was validated. Time-and frequency-domain analyses were performed as follows:
(i) Time-domain analysis: Because it is not clear how to best define CFAEs and the criteria for CFAEs have never been validated, two novel algorithms were developed to describe CFAEs. Instead of using arbitrary cut-off values, CFAEs were described using two continuous parameters and were compared accordingly. These parameters were complexity index (CI) based on how often depolarizations changed polarity per second, and fractionation index (FI) based on how often the direction (polarity) of the depolarization slope (dV/dt) changed per second (Fig. 1) .
(ii) Frequency-domain analysis: As described previously, the dominant frequency (DF) was defined as the frequency of the highest peak of the periodogram in the interval of 0.5 to 20 Hz using Fast Fourier Transformation (Fig. 2) . 
Postablation Care and Follow-Up
All patients were treated with intravenous heparin during an overnight hospital stay, and were discharged home the next morning on warfarin and low molecular weight heparin until the INR was > 2.0. Patients who had been taking a rhythmcontrol drug before ablation were continued on the same drug therapy for 8-12 weeks after the procedure.
The patients were seen in an outpatient clinic 3 months after the ablation procedure and every 3-6 months thereafter. Patients were also contacted periodically by a nurse and were advised to contact the clinical center whenever they experienced symptoms suggestive of an arrhythmia. A 30-day autotriggered event monitor was provided to all patients 6 months after the ablation procedure. Any episode of AF that lasted at least 30 seconds beyond 8 weeks after the ablation procedure was considered to be a recurrence of AF. Unless the patient had a history of stroke or a transient ischemic episode, anticoagulation with warfarin was discontinued at 6 months postablation if there was no evidence of symptomatic or asymptomatic AF. 8 The mean duration of followup was 10 ± 2 months.
Statistical Analysis
Continuous variables are expressed as mean ± 1 standard deviation and were compared by Student's t-test or paired ttest as appropriate. Categorical variables were compared by Chi-square analysis or with Fisher's exact test where appropriate. A P < 0.05 indicated statistical significance.
Because one of the aims of this study was to determine the relationship between electrogram characteristics and outcome of APVI, the primary clinical outcome was freedom from recurrent AF in the absence of antiarrhythmic drug therapy after a single ablation procedure. 
For better resolution a 300 ms window is magnified (Panels B and C). Complexity index was defined as the number of changes in polarity per second (red dots, Panel B). Fractionation index was defined as the number of changes in the direction of depolarization (polarity of dV/dt) per second (red dots, Panel C). The open green circles indicate the detection of peak electrogram amplitude. The red dots indicate effective detection points. The red lines indicate the thresholds for detection and the blue dots indicate data points below the detection threshold.
Results
Time-and Frequency-Domain Characteristics of CS Electrograms Before Ablation
The mean CI was 49 ± 14/s before ablation, with no difference between paroxysmal AF (48 ± 15/s) and persistent AF (50 ± 15/s, P = 0.4). The mean FI before ablation was 82 ± 30/s. There was a trend toward a higher FI in patients with persistent AF (87 ± 30/s), compared with paroxysmal AF (74 ± 28/s, P = 0.05, Table 1 ).
Comparing patients with induced versus spontaneous AF, there were no significant differences in either the mean CI (50 ± 14/s vs 44 ± 16/s, respectively, P = 0.3) or the mean FI (76 ± 28/s vs 70 ± 30/s, P = 0.6), respectively. There was a significant correlation between CI and FI (r = 0.87, P < 0.001, Fig. 3 ).
The mean DF in the CS before APVI was 6.2 ± 0.8 Hz. There was no significant difference in DF between patients with paroxysmal AF (6.1 ± 0.9 Hz) and persistent AF (6.2 ± 0.8 Hz, P = 0.3). The DF was similar in patients with induced versus spontaneous AF (6.0 ± 0.9 Hz vs 6.1 ± 1.0 Hz, respectively, P = 0.8). There was not a significant correlation between CI and DF (r = 0.17, P = 0.2) or between FI and DF (r = 0.06, P = 0.6). There was no significant relationship between CI, FI, and DF and the presence or type of structural heart disease. 
Effects of Antral PV Isolation
The mean duration of radiofrequency energy application was longer in patients with persistent AF, 60 ± 12 min, than paroxysmal AF, 53 ± 11 (P = 0.007). There was a direct correlation between the duration of radiofrequency energy application and the percent decrease in CS DF after APVI in patients with paroxysmal AF (r = 0.49, P = 0.005), but not in patients with persistent AF (P = 0.7).
APVI resulted in a significant decrease in CS CI in paroxysmal AF (48 ± 15/s vs 41 ± 13/s, P = 0.002) and persistent AF (50 ± 15/s vs 42 ± 13/s, P < 0.001, Fig. 4 ). There was no significant difference in the percent decrease in CI between patients with paroxysmal AF or persistent AF (13 ± 19% vs 15 ± 20%, respectively P = 0.6). There also was a significant decrease in FI after APVI (82 ± 30/s vs 71 ± 32, P < 0.001).
APVI resulted in a significant decrease in DF in patients with paroxysmal AF (6.1 ± 0.9 Hz vs 5.0 ± 0.9 Hz, P < 0.001) and persistent AF (6.2 ± 0.8 vs 5.6 ± 0.9, P < 0.001, Fig. 4 ). The percent decrease in DF in the CS was significantly greater in paroxysmal AF (18 ± 12%) than in persistent AF (10 ± 10%, P = 0.003). Data are shown as mean ± SD. Freedom from AF was assessed after a single ablation procedure. AF terminated in only six patients with persistent AF. * = P < 0.05 (for comparisons between columns), †= P < 0.07 (for comparisons between columns), ‡= P < 0.05 (for change in DF), §= P < 0.05 for comparisons between pre-and postablation data (between the rows). RF= ablation, pre-RF= before ablation, post-RF = after ablation. 
Termination of AF During Antral PV Isolation
AF terminated during APVI in 18 of 32 patients (56%) with paroxysmal AF, and in 6 of 45 patients (13%) with persistent AF (P < 0.001). In patients with paroxysmal AF, the baseline CI in the CS was significantly lower in patients in whom AF terminated (43 ± 13/s) than in whom AF did not terminate by ablation (54 ± 14/s, P = 0.03). Similarly, termination of AF by APVI was associated with a lower baseline CS FI (64 ± 23/s vs 87 ± 30/s, P = 0.02).
After APVI, the CI (35 ± 12/s vs 50 ± 10/s, P < 0.001) and FI (49 ± 20/s vs 81 ± 25/s, P < 0.001) were lower in patients with paroxysmal AF in whom AF terminated by ablation than in those in whom AF did not terminate by ablation.
There was no significant difference in baseline CI (47 ± 11/s vs 51 ± 15/s, P = 0.6) or FI (80 ± 31/s vs 89 ± 30/s, P = 0.5) between patients with persistent AF who did and did not have termination of AF during ablation, respectively.
The baseline DF in the CS was similar between patients with paroxysmal AF who did (6.1 ± 0.8 Hz) and did not (6.1 ± 1.0 Hz) have termination of AF during ablation (P = 1.0). The baseline DF also was similar between patients with persistent AF who did and did not have AF terminated by ablation (6.1 ± 0.6 vs 6.2 ± 0.8 Hz, P = 0.8).
There was no significant difference in the percent change in DF when AF terminated during ablation and when it did not among patients with paroxysmal AF (-18 ± 13% vs -17 ± 11%, P = 0.8) or persistent AF (-17 ± 11% vs -9 ± 10%, P = 0.10).
Electrogram Characteristics and Freedom from Recurrent AF
During a mean follow-up of 10 ± 2 months, 22 of 32 patients with paroxysmal AF (69%) and 22 of 45 patients with persistent AF (49%) were free from recurrent AF and antiarrhythmic drug therapy after a single ablation procedure (P = 0.08). Among the patients with paroxysmal AF, 15 of 18 patients (83%) who had termination of AF during APVI, and 7 of 14 patients (50%) who still were in AF after APVI were free from recurrent AF (P = 0.04).
The baseline CI in the CS was higher in patients with paroxysmal AF who had recurrent AF during follow-up, 56 ± 20/s, than in those who did not, 44 ± 10/s (P = 0.03). There was a trend toward a higher baseline FI in patients with than in patients without recurrent AF after ablation (88 ± 40/s vs 68 ± 19/s, P = 0.07).
In patients with persistent AF, there was no significant difference in baseline CI (52 ± 16 vs 49 ± 14/s, P = 0.5) or FI (90 ± 31/s vs 86 ± 29/s, P = 0.6) between patients who did and did not have recurrent AF.
In patients with paroxysmal AF, there was a significantly higher CI after APVI in patients with recurrent AF, 48 ± 16/s, than in patients without recurrent AF, 38 ± 11/s (P < 0.05). The FI after APVI was 76 ± 36/s and 57 ± 20/s in patients with and without recurrent AF, respectively (P = 0.06). There was no significant difference in CI (42 ± 13/s vs 42 ± 13/s, P = 0.8) or FI (78 ± 41/s vs 74 ± 28/s, P = 0.7) after APVI among patients with persistent AF who did and did not have recurrent AF.
There was no significant difference in baseline DF in the CS in patients with paroxysmal AF (6.1 ± 1.0 Hz vs 6.1 ± 0.9 Hz, P = 1.0) or persistent AF (6.4 ± 0.8 Hz vs 6.1 ± 0.7 Hz, P = 0.14) who did and did not have recurrent AF after ablation, respectively.
In patients with paroxysmal AF, there was no significant difference in the percent decrease in DF between patients with and without recurrence of AF (18 ± 11% vs 18 ± 12%, P = 1.0). However, among patients with persistent AF, the percent decrease in DF was significantly larger in patients who remained free from AF (13 ± 11%) than in those who had recurrent AF (7 ± 9%, P < 0.05).
Discussion
Main Findings
This study demonstrates the following: (1) electrogram complexity and DF in the CS are similar in paroxysmal and persistent AF; (2) APVI decreases both the complexity and DF of CS electrograms in patients with paroxysmal and persistent AF, but to a greater extent in patients with paroxysmal AF; (3) lesser complexity of CS electrograms in the baseline state is associated with a higher probability of termination of AF during APVI in patients with paroxysmal AF but not persistent AF; (4) a higher degree of complexity of CS electrograms at baseline is associated with a higher probability of recurrence of AF after a single ablation procedure in patients with paroxysmal but not persistent AF; (5) the degree to which DF decreases after APVI correlates with a higher probability of freedom from recurrent AF in patients with persistent AF.
Taken together, these findings suggest that the complexity of CS electrograms reflects the presence of arrhythmogenic mechanisms of AF that extend beyond the PVs and their antra.
Complexity/Fractionation Index and Dominant Frequency
CFAEs generally have been defined as: (1) discrete electrograms that have a short cycle length, often <120 ms (>8.3 Hz); or 2) fractionated and/or continuous electrograms. Electrograms with a short cycle length may indicate focal drivers of AF such as PV tachycardias or rotors. 9 Fractionated and/or continuous electrograms may indicate slow conduction or block, and therefore are likely to reflect reentrant mechanisms.
1 However, it also is possible that CFAEs simply reflect overlapping muscle fibers and/or anisotropy. In this study, two parameters of complexity and fractionation were analyzed as continuous variables without introducing any arbitrary criteria. The CI and FI used in this study were developed to reflect both fractionated/continuous and high-frequency electrograms, whereas the DF identifies primarily high-frequency electrograms. Furthermore, because the electrograms were sampled for 60 seconds, the data were not influenced by arbitrarily defined sampling durations of a few seconds.
Characteristics of CS Electrograms
There was no significant difference in the complexity of electrograms recorded within the CS between patients with paroxysmal and persistent AF. Consistent with the findings of a prior study, DF within the CS also was similar in patients with paroxysmal and persistent AF. 7 However, it has been reported that DF in the left atrium usually is higher and CFAEs in the left atrium are more prevalent in persistent than in paroxysmal AF. 7 Patients with persistent AF are expected to have more electroanatomical remodeling than patients with paroxysmal AF, and because CS electrograms were not any more complex in persistent than paroxysmal AF, it is unlikely that CFAEs within the CS develop primarily due to a result of electroanatomical remodeling. Because there was no relationship between the CI or FI and the DF within the CS in this study, CFAEs observed within the CS do not appear to be simply due to local areas of short cycle length. 5, 12 Instead, CFAEs within the CS may reflect anisotropic conduction and the complex histological structure of the CS, or primary drivers in the CS. 6, [13] [14] [15] [16] 
Effects of APVI on CS Electrograms
APVI resulted in a decrease in CI, FI, and DF in patients with paroxysmal and persistent AF. Prior studies also have demonstrated that elimination of primary drivers of AF in the PVs and left atrium may decrease DF or mean cycle length within the left atrium and/or CS. 7, 17 Possible explanations include: (1) APVI may eliminate reentrant mechanisms that utilize the CS musculature; (2) arrhythmogenic mechanisms specific to the CS may require the presence of primary drivers that originate in the PVs or left atrium. Elimination of these primary drivers may cause secondary drivers in the CS to extinguish, similar to the dynamic interplay that occurs between the PVs and left atrium during AF; 18 (3) elimination of primary drivers of AF results in a decrease in DF in the left atrium and CS. The extent to which each of these explanations contributes to the effect of APVI on CS electrograms is conjectural.
Electrogram Characteristics and Termination of AF During APVI
An association between the baseline complexity of CS electrograms and the acute and long-term response to APVI was observed in patients with paroxysmal AF. It is conceivable that mechanisms of AF not readily eliminated by APVI may be reflected in the complexity of CS electrograms in patients with paroxysmal AF.
Consistent with the findings of a prior study, there was an association between a decrease in DF after APVI and freedom from recurrent AF in patients with persistent AF. 7 It is possible that most or all drivers of AF were limited to the antral regions in some patients with persistent AF. Elimination of a sufficient number of these drivers could have resulted in a greater decrease in DF and higher probability of freedom from recurrent AF.
Prior Studies
In a prior study, AF was less likely to be inducible after electrical disconnection of the CS from the left atrium following PV isolation by segmental ostial ablation in 22 patients with paroxysmal AF. 19 The site of intermittent rapid tachycardia alternated between the CS and the left atrium similar to the dynamic interplay that occurs between the PVs and the left atrium. 18 Consistent with these prior observations, the findings of this study also suggest a mechanistic role of the CS in perpetuation of AF. In a recent study, radiofrequency catheter ablation was performed along the endocardial and epicardial aspects of the CS in 15 patients with paroxysmal AF and 40 patients with persistent AF who remained in AF after PV isolation. 20 CS ablation was associated with termination of AF in 46% of patients with paroxysmal and 30% of patients with persistent AF. AF termination was associated with more rapid activity within the CS. Unlike in this study, the only electrogram characteristic that was analyzed was cycle length. Furthermore, the ablation strategy was limited to PV isolation without antral ablation. There was no control group of subjects who did not undergo CS ablation; and in patients with persistent AF, CS ablation was often performed in the course of additional left atrial ablation. Termination of AF during ablation within CS suggests that at least some drivers of AF utilize the musculature of the CS. Consistent with these observations, this study indicates that greater complexity of CS electrograms, particularly in patients with paroxysmal AF, may identify those who are more likely to have drivers utilizing the CS.
Limitations
A limitation of this study is that CFAEs within the CS were not targeted for ablation, and, therefore, the clinical significance of these CFAEs cannot be proven.
Because simultaneous multisite mapping of the PVs and left atrium was not performed, the interaction between the CS and these potentially arrhythmogenic sites cannot be demonstrated.
The small number of patients with persistent AF who had termination of AF may have precluded the detection of a significant relationship between the characteristics of CS electrograms and AF termination.
Future Directions
Future studies are necessary to determine whether elimination of extra-PV drivers utilizing the CS improves the clinical efficacy of catheter ablation in patients with paroxysmal AF. The relationship and interdependence of drivers in the left atrium and CS remain to be examined, particularly in patients with persistent AF.
